… investors and patients by hailing her company’s blood-testing technology as a medical breakthrough when in fact it was prone to wild errors.
… investors and patients by hailing her company’s blood-testing technology as a medical breakthrough when in fact it was prone to wild errors.
lecrab 
lecrab